Desmosomes: Regulators of cellular signaling and adhesion in epidermal health and disease

Cold Spring Harbor Perspectives in Medicine

Volumn 4, Issue 11, 2014, Pages

  Johnson, Jodi L ^a   Najor, Nicole A ^a   Green, Kathleen J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; DESMOSOMAL CADHERIN; ENVOPLAKIN; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KERATIN; KRUPPEL LIKE FACTOR 4; KRUPPEL LIKE FACTOR 5; LYMPHOID ENHANCER FACTOR 1; MYOD PROTEIN; NOTCH RECEPTOR; PERIPLAKIN; PROTEIN KINASE C; PROTEIN P53; PROTEIN P63; SMAD1 PROTEIN; SMAD4 PROTEIN; SMAD5 PROTEIN; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR CDX1; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR PEA3; TRANSCRIPTION FACTOR PIT 1; TRANSCRIPTION FACTOR SLUG;

ARTICLE; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CELL JUNCTION; DESMOSOME; DISEASES; EPIDERMIS; HAIR FOLLICLE; HEART DISEASE; HUMAN; KERATINOCYTE; PROTEIN EXPRESSION; SKIN; TRANSCRIPTION REGULATION; WOUND HEALING; CELL ADHESION; CELL COMMUNICATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GROWTH, DEVELOPMENT AND AGING; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKIN DISEASE;

AUTOIMMUNE DISEASES; CELL ADHESION; CELL COMMUNICATION; DESMOSOMES; EPIDERMIS; GENE EXPRESSION REGULATION; HUMANS; SIGNAL TRANSDUCTION; SKIN DISEASES; SKIN DISEASES, GENETIC;

EID: 84923872627     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a015297     Document Type: Article

References (177)

1. Adams MJ, Reichel MB, King IA, Marsden MD, Greenwood MD, Thirlwell H, Arnemann J, Buxton RS, Ali RR. 1998. Characterization of the regulatory regions in the human desmoglein genes encoding the pemphigus foliaceous and pemphigus vulgaris antigens. Biochem J 329: 165– 174.
2. Aho S, Rothenberger K, Tan EM, Ryoo YW, Cho BH, McLean WH, Uitto J. 1999.Human periplakin: Genomic organization in a clonally unstable region of chromosome 16p with an abundance of repetitive sequence elements. Genomics 56: 160–168.
3. Aigner K, Descovich L, Mikula M, Sultan A, Dampier B, Bonne S, van Roy F, Mikulits W, Schreiber M, Brabletz T, et al. 2007. The transcription factor ZEB1 (dEF1) represses Plakophilin 3 during human cancer progression. FEBS Lett 581: 1617–1624.
4. Aijaz S, Sanchez-Heras E, Balda MS, Matter K. 2007. Regulation of tight junction assembly and epithelial morphogenesis by the heat shock protein Apg-2. BMC Cell Biol 8: 49.
5. Aktary Z, Pasdar M. 2012. Plakoglobin: Role in tumorigenesis and metastasis. Int J Cell Biol 2012: 189521.
6. Allen E, Yu QC, Fuchs E. 1996. Mice expressing a mutant desmosomal cadherin exhibit abnormalities in desmosomes, proliferation, and epidermal differentiation. J Cell Biol 133: 1367–1382.
7. Amagai M, Stanley JR. 2012. Desmoglein as a target in skin disease and beyond. J Invest Dermatol 132: 776–784.
8. Amagai M, Klaus-Kovtun V, Stanley JR. 1991. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67: 869–877.
9. Arnemann J, Spurr NK, Wheeler GN, Parker AE, Buxton RS. 1991. Chromosomal assignment of the human genes coding for the major proteins of the desmosome junction, desmoglein DGI (DSG), desmocollins DGII/III (DSC), desmoplakins DPI/II (DSP), and plakoglobin DPIII (JUP). Genomics 10: 640–645.
10. Asimaki A, Tandri H, Huang H, Halushka MK, Gautam S, Basso C, Thiene G, Tsatsopoulou A, Protonotarios N, McKenna WJ, et al. 2009. A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med 360: 1075–1084.
11. Bailey CK, Mittal MK, Misra S, Chaudhuri G. 2012. High motility of triple-negative breast cancer cells is due to repression of plakoglobin gene by metastasis modulator protein SLUG. J Biol Chem 287: 19472–19486.
12. Baron S, Hoang A, Vogel H, Attardi LD. 2012. Unimpaired skin carcinogenesis in desmoglein 3 knockout mice. PLoS ONE 7: 50024.
13. Bass-Zubek AE, Hobbs RP, Amargo EV, Garcia NJ, Hsieh SN, Chen X, Wahl JK III, Denning MF, Green KJ. 2008. Plakophilin 2: A critical scaffold for PKC-a that regulates intercellular junction assembly. J Cell Biol 181: 605–613.
14. Bayerl C, Taake S, Moll I, Jung EG. 1995. Characterization of sunburn cells after exposure to ultraviolet light. Photodermatol Photoimmunol Photomed 11: 149–154.
15. Bayo P, Sanchis A, Bravo A, Cascallana JL, Buder K, Tuckermann J, Schutz G, Perez P. 2008. Glucocorticoid receptor is required for skin barrier competence. Endocrinology 149: 1377–1388.
16. Bazzi H, Christiano AM. 2007. Broken hearts, woolly hair, and tattered skin: When desmosomal adhesion goes awry. Curr Opin Cell Biol 19: 515–520.
17. Bazzi H, Demehri S, Potter CS, Barber AG, Awgulewitsch A, Kopan R, Christiano AM. 2009. Desmoglein 4 is regulated by transcription factors implicated in hair shaft differentiation. Differentiation 78: 292–300.
18. Beaudry VG, Jiang D, Dusek RL, Park EJ, Knezevich S, Ridd K, Vogel H, Bastian BC, Attardi LD. 2010. Loss of the p53/p63 regulated desmosomal protein Perp promotes tumorigenesis. PLoS Genet 6: 1001168.
19. Bektas M, Jolly P, Rubenstein DS. 2010. Apoptotic pathways in pemphigus. Dermatol Res Pract 2010: 456841.
20. Bonne S, van Hengel J, van Roy F. 1998. Chromosomal mapping of human armadillo genes belonging to the pp120(ctn)/plakophilin subfamily. Genomics 51: 452–454.
21. Brennan D, Mahoney MG. 2009. Increased expression of Dsg2 in malignant skin carcinomas: A tissue-microarray based study. Cell Adh Migr 3: 148–154.
22. Brennan D, Hu Y, Joubeh S, Choi YW, Whitaker-Menezes D, O’Brien T, Uitto J, Rodeck U, Mahoney MG. 2007. Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes. J Cell Sci 120: 758–771.
23. Brennan D, Hu Y, Medhat W, Dowling A, Mahoney MG. 2010. Superficial dsg2 expression limits epidermal blister formation mediated by pemphigus foliaceus antibodies and exfoliative toxins. Dermatol Res Pract 2010: 410278.
24. Byrne C, Tainsky M, Fuchs E. 1994. Programming gene expression in developing epidermis. Development 120: 2369–2383.
25. Cabral RM, Liu L, Hogan C, Dopping-Hepenstal PJ, Winik BC, Asial RA, Dobson R, Mein CA, Baselaga PA, Mellerio JE, et al. 2010. Homozygous mutations in the 50 region of the JUP gene result in cutaneous disease but normal heart development in children. J Invest Dermatol 130: 1543–1550.
26. Chang YT, Tsai SF, Lee DD, Shiao YM, Huang CY, Liu HN, Wang WJ, Wong CK. 2003. A study of candidate genes for psoriasis near HLA-C in Chinese patients with psoriasis. Br J Dermatol 148: 418–423.
27. Chang YT, Chou CT, Shiao YM, Lin MW, Yu CW, Chen CC, Huang CH, Lee DD, Liu HN, Wang WJ, et al. 2006. Psoriasis vulgaris in Chinese individuals is associated with PSORS1C3 and CDSN genes. Br J Dermatol 155: 663-669.
28. Charpentier E, Lavker RM, Acquista E, Cowin P. 2000. Plakoglobin suppresses epithelial proliferation and hair growth in vivo. J Cell Biol 149: 503–520.
29. Chen X, Bonne S, Hatzfeld M, van Roy F, Green KJ. 2002. Protein binding and functional characterization of plakophilin 2. Evidence for its diverse roles in desmosomes and beta-catenin signaling. J Biol Chem 277: 10512–10522.
30. Chidgey M, Brakebusch C, Gustafsson E, Cruchley A, Hail C, Kirk S, Merritt A, North A, Tselepis C, Hewitt J, et al. 2001. Mice lacking desmocollin 1 show epidermal fragility accompanied by barrier defects and abnormal differentiation. J Cell Biol 155: 821–832.
31. Chouinard N, Rouabhia M. 1999. Effects of all-trans retinoic acid on UVB-irradiated human skin substitute. J Cell Physiol 181: 14–23.
32. Chu YS, Thomas WA, Eder O, Pincet F, Perez E, Thiery JP, Dufour S. 2004. Force measurements in E-cadherin-mediated cell doublets reveal rapid adhesion strengthened by actin cytoskeleton remodeling through Rac and Cdc42. J Cell Biol 167: 1183–1194.
33. Chun MG, Hanahan D. 2010. Genetic deletion of the desmosomal component desmoplakin promotes tumor microinvasion in a mouse model of pancreatic neuroendocrine carcinogenesis. PLoS Genet 6: 1001120.
34. Cirillo N, Al-Jandan BA. 2013. Desmosomal adhesion and pemphigus vulgaris: The first half of the story. Cell Commun Adhes 20: 1–10.
35. Cowley CM, Simrak D, Marsden MD, King IA, Arnemann J, Buxton RS. 1997a. AYAC contig joining the desmocollin and desmoglein loci on human chromosome 18 and ordering of the desmocollin genes. Genomics 42: 208–216.
36. Cowley CM, Simrak D, Spurr NK, Arnemann J, Buxton RS. 1997b. The plakophilin 1 (PKP1) and plakoglobin (JUP) genes map to human chromosomes 1q and 17, respectively. Hum Genet 100: 486–488.
37. Cui T, Chen Y, Yang L, Knosel T, Zoller K, Huber O, Petersen I. 2011. DSC3 expression is regulated by pp53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer. Br J Cancer 104: 1013–1019.
38. Delva E, Tucker DK, Kowalczyk AP. 2009. The desmosome. Cold Spring Harb Perspect Biol 1: 002543.
39. Denning MF, Guy SG, Ellerbroek SM, Norvell SM, Kowalczyk AP, Green KJ. 1998. The expression of desmoglein isoforms in cultured human keratinocytes is regulated by calcium, serum, and protein kinase C. Exp Cell Res 239: 50–59.
40. Descargues P, Deraison C, Prost C, Fraitag S, Mazereeuw-Hautier J, D’Alessio M, Ishida-Yamamoto A, Bodemer C, Zambruno G, Hovnanian A. 2006. Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin and chymotrypsin-like hyperactivity in Netherton syndrome. J Invest Dermatol 126: 1622–1632.
41. Dong JT, Chen C. 2009. Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases. Cell Mol Life Sci 66: 2691–2706.
42. Dubash AD, Koetsier JL, Amargo EV, Najor NA, Harmon RM, Green KJ. 2013. The GEF Bcr activates RhoA/MAL signaling to promote keratinocyte differentiation via desmoglein 1. J Cell Biol 202: 653–666.
43. Dusek RL, Attardi LD. 2011. Desmosomes: New perpetrators in tumour suppression. Nat Rev Cancer 11: 317–323.
44. Dusek RL, Getsios S, Chen F, Park JK, Amargo EV, Cryns VL, Green KJ. 2006. The differentiation-dependent desmosomal cadherin desmoglein 1 is a novel caspase-3 target that regulates apoptosis in keratinocytes. J Biol Chem 281: 3614–3624.
45. Dusek RL, Godsel LM, Chen F, Strohecker AM, Getsios S, Harmon R, Muller EJ, Caldelari R, Cryns VL, Green KJ. 2007. Plakoglobin deficiency protects keratinocytes from apoptosis. J Invest Dermatol 127: 792–801.
46. Elias PM, Matsuyoshi N, Wu H, Lin C, Wang ZH, Brown BE, Stanley JR. 2001. Desmoglein isoform distribution affects stratum corneum structure and function. J Cell Biol 153: 243–249.
47. Eshkind L, Tian Q, Schmidt A, Franke WW, Windoffer R, Leube RE. 2002. Loss of desmoglein 2 suggests essential functions for early embryonic development and proliferation of embryonal stem cells. Eur J Cell Biol 81: 592–598.
48. Ferone G, Mollo MR, Thomason HA, Antonini D, Zhou H, Ambrosio R, De Rosa L, Salvatore D, Getsios S, van Bokhoven H, et al. 2013. p63 control of desmosome gene expression and adhesion is compromised in AEC syndrome. Hum Mol Genet 22: 531–543.
49. Franzen CA, Todorovic V, Desai BV, Mirzoeva S, Yang XJ, Green KJ, Pelling JC. 2012. The desmosomal armadillo protein plakoglobin regulates prostate cancer cell adhesionand motility through vitronectin-dependent Src signaling. PLoS ONE 7: 42132.
50. Frydman AS, Fairley JA. 2011.Newand innovative interventions in the management of pemphigus. G Ital Dermatol Venereol 146: 211–224.
51. Funakoshi S, Ezaki T, Kong J, Guo RJ, Lynch JP. 2008. Repression of the desmocollin 2 gene expression in human colon cancer cells is relieved by the homeodomain transcription factors Cdx1 and Cdx2. Mol Cancer Res 6: 1478–1490.
52. Gallicano GI, Kouklis P, Bauer C, Yin M, Vasioukhin V, Degenstein L, Fuchs E. 1998. Desmoplakin is required early in development for assembly of desmosomes and cytoskeletal linkage. J Cell Biol 143: 2009–2022.
53. Garcia-Gras E, Lombardi R, Giocondo MJ, Willerson JT, Schneider MD, Khoury DS, Marian AJ. 2006. Suppression of canonical Wnt/b-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Clin Invest 116: 2012–2021.
54. Gardel ML, Kasza KE, Brangwynne CP, Liu J, Weitz DA. 2008. Chapter 19: Mechanical response of cytoskeletal networks. Methods Cell Biol 89: 487–519.
55. Garrod DR, Fisher C, Smith A, Nie Z. 2008. Pervanadate stabilizes desmosomes. Cell Adh Migr 2: 161–166.
56. Getsios S, Simpson CL, Kojima S, Harmon R, Sheu LJ, Dusek RL, Cornwell M, Green KJ. 2009. Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis. J Cell Biol 185: 1243–1258.
57. Godsel LM, Dubash AD, Bass-Zubek AE, Amargo EV, Klessner JL, Hobbs RP, Chen X, Green KJ. 2010. Plakophilin 2 couples actomyosin remodeling to desmosomal plaque assembly via RhoA. Mol Biol Cell 21: 2844–2859.
58. Grando SA. 2012. Pemphigus autoimmunity: Hypotheses and realities. Autoimmunity 45: 7–35.
59. Green KJ, Gaudry CA. 2000. Are desmosomes more than tethers for intermediate filaments? Nat Rev Mol Cell Biol 1: 208–216.
60. Green KJ, Simpson CL. 2007. Desmosomes: New perspectives on a classic. J Invest Dermatol 127: 2499–2515.
61. Green KJ, Getsios S, Troyanovsky S, Godsel LM. 2010. Intercellular junction assembly, dynamics, and homeostasis. Cold Spring Harb Perspect Biol 2: 000125.
62. Groot KR, Sevilla LM, Nishi K, DiColandrea T, Watt FM. 2004. Kazrin, a novel periplakin-interacting protein associated with desmosomes and the keratinocyte plasma membrane. J Cell Biol 166: 653–659.
63. Hanakawa Y, Matsuyoshi N, Stanley JR. 2002. Expression of desmoglein 1 compensates for genetic loss of desmoglein 3 in keratinocyte adhesion. J Invest Dermatol 119: 27–31.
64. Hardman MJ, Liu K, Avilion AA, Merritt A, Brennan K, Garrod DR, Byrne C. 2005. Desmosomal cadherin misexpression alters b-catenin stability and epidermal differentiation. Mol Cell Biol 25: 969–978.
65. Harmon RM, Simpson CL, Johnson JL, Koetsier JL, Dubash AD, Najor NA, Sarig O, Sprecher E, Green KJ. 2013. Desmoglein 1/Erbin interaction suppresses ERK activation to support epidermal differentiation. J Clin Invest 123: 1556–1570.
66. Hartlieb E, Kempf B, Partilla M, Vigh B, Spindler V, Waschke J. 2013. Desmoglein 2 is less important than desmoglein 3 for keratinocyte cohesion. PLoS ONE 8: e53739.
67. Henkler F, Strom M, Mathers K, Cordingley H, Sullivan K, King I. 2001. Trangenic misexpression of the differentiation specific desmocollin isoform 1 in basal keratinocytes. J Invest Dermatol 116: 144–149.
68. Hobbs RP, Amargo EV, Somasundaram A, Simpson CL, Prakriya M, Denning MF, Green KJ. 2011. The calcium ATPase SERCA2 regulates desmoplakin dynamics and intercellular adhesive strength through modulation of PKC-a signaling. FASEB J 25: 990–1001.
69. Hofmann I, Casella M, Schnolzer M, Schlechter T, Spring H, FrankeWW. 2006. Identification of the junctional plaque protein plakophilin 3 in cytoplasmic particles containing RNA-binding proteins and the recruitment of plakophilins 1 and 3 to stress granules. Mol Biol Cell 17: 1388–1398.
70. Hovnanian A. 2013. Netherton syndrome: Skin inflammation and allergy by loss of protease inhibition. Cell Tissue Res 351: 289–300.
71. Humphries JD, Parry EJ, Watson RE, Garrod DR, Griffiths CE. 1998. All-trans retinoic acid compromises desmosome expression in human epidermis. Br J Dermatol 139: 577–584.
72. Ihrie RA, Attardi LD. 2005. A new Perp in the lineup: Linking p63 and desmosomal adhesion. Cell Cycle 4: 873–876.
73. Johnson JL, Koetsier JL, Sirico A, Agidi AT, Antonini D, Missero C, Green KJ. 2014. The desmosomal protein desmoglein 1 aids recovery of epidermal differentiation after acute ultraviolet light exposure. J Invest Dermatol doi: 10.1038/jid.2014.124.
74. Kalantari-Dehaghi M, Anhalt GJ, Camilleri MJ, Chernyavsky AI, Chun S, Felgner PL, Jasinskas A, Leiferman KM, Liang L, Marchenko S, et al. 2013. Pemphigus vulgaris autoantibody profiling by proteomic technique. PLoS ONE 8: 57587.
75. Kaz AM, Luo Y, Dzieciatkowski S, Chak A, Willis JE, Upton MP, Leidner RS, Grady WM. 2012. Aberrantly methylated PKP1 in the progression of Barrett’s esophagus to esophageal adenocarcinoma. Genes Chromosomes Cancer 51: 384–393.
76. Kenchegowda D, Harvey SA, Swamynathan S, Lathrop KL, Swamynathan SK. 2012. Critical role of Klf5 in regulating gene expression during post-eyelid opening maturation of mouse corneas. PLoS ONE 7: 44771.
77. Khapare N, Kundu ST, Sehgal L, Sawant M, Priya R, Gosavi P, Gupta N, Alam H, Karkhanis M, Naik N, et al. 2012. Plakophilin3 loss leads to an increase in PRL3 levels promoting K8 dephosphorylation, which is required for transformation and metastasis. PLoS ONE 7: 38561.
78. Kim MY, Lee SE, Chang JY, Kim SC. 2011. Retinoid induces the degradation of corneodesmosomes and downregulation of corneodesmosomal cadherins: Implications on the mechanism of retinoid-induced desquamation. Ann Dermatol 23: 439–447.
79. Kimura TE, Merritt AJ, Lock FR, Eckert JJ, Fleming TP, Garrod DR. 2012. Desmosomal adhesiveness is developmentally regulated in the mouse embryo and modulated during trophectoderm migration. Dev Biol 369: 286–297.
80. Klessner JL, Desai BV, Amargo EV, Getsios S, Green KJ. 2009. EGFR and ADAMs cooperate to regulate shedding and endocytic trafficking of the desmosomal cadherin desmoglein 2. Mol Biol Cell 20: 328–337.
81. Kljuic A, Bazzi H, Sundberg JP, Martinez-Mir A, O’Shaughnessy R, Mahoney MG, Levy M, Montagutelli X, Ahmad W, Aita VM, et al. 2003. Desmoglein 4 in hair follicle differentiation and epidermal adhesion: Evidence from inherited hypotrichosis and acquired pemphigus vulgaris. Cell 113: 249–260.
82. Kolegraff K, Nava P, Helms MN, Parkos CA, Nusrat A. 2011. Loss of desmocollin-2 confers a tumorigenic phenotype to colonic epithelial cells through activation of Akt/bcatenin signaling. Mol Biol Cell 22: 1121–1134.
83. Koulu L, Kusumi A, Steinberg MS, Klaus-Kovtun V, Stanley JR. 1984. Human autoantibodies against a desmosomal core protein in pemphigus foliaceus. J Exp Med 160: 1509–1518.
84. Kowalczyk AP, Green KJ. 2013. Structure, function, and regulation of desmosomes. Prog Mol Biol Transl Sci 116: 95–118.
85. Kroger C, Loschke F, Schwarz N, Windoffer R, Leube RE, Magin TM. 2013. Keratins control intercellular adhesion involving PKC-a-mediated desmoplakin phosphorylation. J Cell Biol 201: 681–692.
86. Lebeau S, Masouye I, Berti M, Augsburger E, Saurat JH, Borradori L, Fontao L. 2005. Comparative analysis of the expression of ERBIN and Erb-B2 in normal human skin and cutaneous carcinomas. Br J Dermatol 152: 1248–1255.
87. Lechler T, Fuchs E. 2007. Desmoplakin: An unexpected regulator of microtubule organization in the epidermis. J Cell Biol 176: 147–154.
88. Leclerc EA, Huchenq A, Mattiuzzo NR, Metzger D, Chambon P, Ghyselinck NB, Serre G, Jonca N, Guerrin M. 2009. Corneodesmosin gene ablation induces lethal skin-barrier disruption and hair-follicle degeneration related to desmosome dysfunction. J Cell Sci 122: 2699–2709.
89. Leitner L, Shaposhnikov D, Mengel A, Descot A, Julien S, Hoffmann R, Posern G. 2011. MAL/MRTF-A controls migration of non-invasive cells by upregulation of cytoskeleton associated proteins. J Cell Sci 124: 4318–4331.
90. Li D, Turi TG, Schuck A, Freedberg IM, Khitrov G, Blumenberg M. 2001. Rays and arrays: The transcriptional program in the response of human epidermal keratinocytes to UVB illumination. FASEB J 15: 2533–2535.
91. Li D, Zhang W, Liu Y, Haneline LS, Shou W. 2012. Lack of plakoglobin in epidermis leads to keratoderma. J Biol Chem 287: 10435–10443.
92. Lin S, Gordon K, Kaplan N, Getsios S. 2010. Ligand targeting of EphA2 enhances keratinocyte adhesion and differentiation via desmoglein 1. Mol Biol Cell 21: 3902–3914.
93. Loffek S, Bruckner-Tuderman L, Magin TM. 2012. Involvement of the ubiquitin-proteasome system in the stabilization of cell-cell contacts in human keratinocytes. Exp Dermatol 21: 791–793.
94. Lopez-Pajares V, Yan K, Zarnegar BJ, Jameson KL, Khavari PA. 2013. Genetic pathways in disorders of epidermal differentiation. Trends Genet 29: 31–40.
95. Lorch JH, Klessner J, Park JK, Getsios S, Wu YL, Stack MS, Green KJ. 2004. Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells. J Biol Chem 279: 37191–37200.
96. Maatta A, Ruhrberg C, Watt FM. 2000. Structure and regulation of the envoplakin gene. J Biol Chem 275: 19857– 19865.
97. MacRae CA, Birchmeier W, Thierfelder L. 2006. Arrhythmogenic right ventricular cardiomyopathy: Moving toward mechanism. J Clin Invest 116: 1825–1828.
98. Mannan T, Jing S, Foroushania SH, Fortune F, Wan H. 2011. RNAi-mediated inhibition of the desmosomal cadherin (desmoglein 3) impairs epithelial cell proliferation. Cell Prolif 44: 301–310.
99. Mao X, Nagler AR, Farber SA, Choi EJ, Jackson LH, Leiferman KM, Ishii N, Hashimoto T, Amagai M, Zone JJ, et al. 2010. Autoimmunity to desmocollin 3 in pemphigus vulgaris. Am J Pathol 177: 2724–2730.
100. Mao X, Sano Y, Park JM, Payne AS. 2011. p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris. J Biol Chem 286: 1283–1291.
101. Mao X, Li H, Sano Y, Gaestel M, Mo Park J, Payne AS. 2013. MAPKAP kinase 2 (MK2)-dependent and independent models of blister formation in pemphigus vulgaris. J Invest Dermatol 134: 68–76.
102. Marsden MD, Collins JE, Greenwood MD, Adams MJ, Fleming TP, Magee AI, Buxton RS. 1997. Cloning and transcriptional analysis of the promoter of the human type 2 desmocollin gene (DSC2). Gene 186: 237–247.
103. Matsuda M, Hoshino T, Yamashita Y, Tanaka K, Maji D, Sato K, Adachi H, Sobue G, Ihn H, Funasaka Y, et al. 2013. Prevention of UVB radiation-induced epidermal damage by expression of heat shock protein 70. J Biol Chem 285: 5848–5858.
104. Merritt AJ, Berika MY, Zhai W, Kirk SE, Ji B, Hardman MJ, Garrod DR. 2002. Suprabasal desmoglein 3 expression in the epidermis of transgenic mice results in hyperprolif eration and abnormal differentiation. Mol Cell Biol 22: 5846–5858.
105. Miralles F, Posern G, Zaromytidou AI, Treisman R. 2003. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113: 329–342.
106. Mizukoshi K, Matsumoto K, Hirose R, Fujita T, Ishida-Yamamoto A, Iizuka H. 2011. Effects of serine palmitoyltransferase inhibitor ISP-I on the stratum corneum of intact mouse skin. Biol Pharm Bull 34: 1383–1389.
107. Mucke N, Kreplak L, Kirmse R, Wedig T, Herrmann H, Aebi U, Langowski J. 2004. Assessing the flexibility of intermediate filaments by atomic force microscopy. J Mol Biol 335: 1241–1250.
108. Murakami T, Fujimoto M, Ohtsuki M, Nakagawa H. 2001. Expression profiling of cancer-related genes in human keratinocytes following non-lethal ultraviolet B irradiation. J Dermatol Sci 27: 121–129.
109. Nachat R, Cipolat S, Sevilla LM, Chhatriwala M, Groot KR, Watt FM. 2009. KazrinE is a desmosome-associated liprin that colocalises with acetylated microtubules. J Cell Sci 122: 4035–4041.
110. Nava P, Laukoetter MG, Hopkins AM, Laur O, Gerner Smidt K, Green KJ, Parkos CA, Nusrat A. 2007. Desmoglein-2: A novel regulator of apoptosis in the intestinal epithelium. Mol Biol Cell 18: 4565–4578.
111. Nguyen VT, Arredondo J, Chernyavsky AI, Kitajima Y, Grando SA. 2003. Keratinocyte acetylcholine receptors regulate cell adhesion. Life Sci 72: 2081–2085.
112. Nguyen B, Dusek RL, Beaudry VG, Marinkovich MP, Attardi LD. 2009. Loss of the desmosomal protein perp enhances the phenotypic effects of pemphigus vulgaris autoantibodies. J Invest Dermatol 129: 1710–1718.
113. Ning S, Hahn GM. 1994. Formation of tight junctions and desmosomes protects MDCK cells against hyperthermic killing. J Cell Physiol 160: 249–254.
114. Oji V, Eckl KM, Aufenvenne K, Natebus M, Tarinski T, Ackermann K, Seller N, Metze D, Nurnberg G, Folster-Holst R, et al. 2010. Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: Unraveling the peeling skin disease. Am J Hum Genet 87: 274–281.
115. Oshiro MM, Watts GS, Wozniak RJ, Junk DJ, Munoz-Rodriguez JL, Domann FE, Futscher BW. 2003.Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression. Oncogene 22: 3624–3634.
116. Owens P, Bazzi H, Engelking E, Han G, Christiano AM, Wang XJ. 2008. Smad4-dependent desmoglein-4 expression contributes to hair follicle integrity. Dev Biol 322: 156–166.
117. Pan H, Gao F, Papageorgis P, Abdolmaleky HM, Faller DV, Thiagalingam S. 2007. Aberrant activation of g-catenin promotes genomic instability and oncogenic effects during tumor progression. Cancer Biol Ther 6: 1638–1643.
118. Parker HR, Li Z, Sheinin H, Lauzon G, Pasdar M. 1998. Plakoglobin induces desmosome formation and epidermoid phenotype in N-cadherin-expressing squamous carcinoma cells deficient in plakoglobin and E-cadherin. Cell Motil Cytoskeleton 40: 87–100.
119. Petrof G, Mellerio JE, McGrath JA. 2012. Desmosomal genodermatoses. Br J Dermatol 166: 36–45.
120. Potter E, Braun S, Lehmann U, Brabant G. 2001. Molecular cloning of a functional promoter of the human plakoglobin gene. Eur J Endocrinol 145: 625–633.
121. Rawlings A, Harding C, Watkinson A, Banks J, Ackerman C, Sabin R. 1995. The effect of glycerol and humidity on desmosome degradation in stratum corneum. Arch Dermatol Res 287: 457–464.
122. Reczek EE, Flores ER, Tsay AS, Attardi LD, Jacks T. 2003. Multiple response elements and differential p53 binding control Perp expression during apoptosis. Mol Cancer Res 1: 1048–1057.
123. Roberts BJ, Pashaj A, Johnson KR, Wahl JK III. 2011. Desmosome dynamics in migrating epithelial cells requires the actin cytoskeleton. Exp Cell Res 317: 2814–2822.
124. Roemer K. 2012. Notch and the p53 clan of transcription factors. Adv Exp Med Biol 727: 223–240.
125. Ruhrberg C, Hajibagheri MA, Parry DA, Watt FM. 1997. Periplakin, a novel component of cornified envelopes and desmosomes that belongs to the plakin family and forms complexes with envoplakin. J Cell Biol 139: 1835–1849.
126. Rundhaug JE, Hawkins KA, Pavone A, Gaddis S, Kil H, Klein RD, Berton TR, McCauley E, Johnson DG, Lubet RA, et al. 2005. SAGE profiling of UV-induced mouse skin squamous cell carcinomas, comparison with acute UV irradiation effects. Mol Carcinog 42: 40–52.
127. Ryan KR, Lock FE, Heath JK, Hotchin NA. 2012. Plakoglobin-dependent regulation of keratinocyte apoptosis by Rnd3. J Cell Sci 125: 3202–3209.
128. Saito M, Stahley SN, Caughman CY, Mao X, Tucker DK, Payne AS, Amagai M, Kowalczyk AP. 2012. Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation. PLoS ONE 7: 50696.
129. Samady L, Faulkes DJ, Budhram-Mahadeo V, Ndisang D, Potter E, Brabant G, Latchman DS. 2006. The Brn-3b POU family transcription factor represses plakoglobin gene expression in human breast cancer cells. Int J Cancer 118: 869–878.
130. Samuelov L, Sarig O, Harmon RM, Rapaport D, Ishida Yamamoto A, Isakov O, Koetsier JL, Gat A, Goldberg I, Bergman R, et al. 2013. Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting. Nat Genet 45: 1244–1248.
131. Sato J, Denda M, Nakanishi J, Koyama J. 1998. Dry condition affects desquamation of stratum corneum in vivo. J Dermatol Sci 18: 163–169.
132. Savagner P, Kusewitt DF, Carver EA, Magnino F, Choi C, Gridley T, Hudson LG. 2005. Developmental transcription factor slug is required for effective re-epithelialization by adult keratinocytes. J Cell Physiol 202: 858–866.
133. Sesto A, Navarro M, Burslem F, Jorcano JL. 2002. Analysis of the ultraviolet B response in primary human keratinocytes using oligonucleotide microarrays. Proc Natl Acad Sci 99: 2965–2970.
134. Sevilla LM, Nachat R, Groot KR, Klement JF, Uitto J, Djian P, Maatta A, Watt FM. 2007. Mice deficient in involucrin, envoplakin, and periplakin have a defective epidermal barrier. J Cell Biol 179: 1599–1612.
135. Sevilla LM, Nachat R, Groot KR, Watt FM. 2008. Kazrin regulates keratinocyte cytoskeletal networks, intercellular junctions and differentiation. J Cell Sci 121: 3561–3569.
136. Sheu HM, Kitajima Y, Yaoita H. 1989. Involvement of protein kinase C in translocation of desmoplakins from cytosol to plasma membrane during desmosome formation in human squamous cell carcinoma cells grown in low to normal calcium concentration. Exp Cell Res 185: 176–190.
137. Shim JS, Kim DH, Kwon HJ. 2004. Plakoglobin is a new target gene of histone deacetylase in human fibrosarcoma HT1080 cells. Oncogene 23: 1704–1711.
138. Silos SA, Tamai K, Li K, Kivirikko S, Kouba D, Christiano AM, Uitto J. 1996. Cloning of the gene for human pemphigus vulgaris antigen (desmoglein 3), a desmosomal cadherin. Characterization of the promoter region and identification of a keratinocyte-specific cis-element. J Biol Chem 271: 17504–17511.
139. Simpson CL, Kojima S, Cooper-Whitehair V, Getsios S, Green KJ. 2010. Plakoglobin rescues adhesive defects induced by ectodomain truncation of the desmosomal cadherin desmoglein: 1. Implications for exfoliative toxinmediated skin blistering. Am J Pathol 177: 2921–2937.
140. Simrak D, Cowley CM, Buxton RS, Arnemann J. 1995. Tandem arrangement of the closely linked desmoglein genes on human chromosome 18. Genomics 25: 591–594.
141. Smith C, Zhu K, Merritt A, Picton R, Youngs D, Garrod D, Chidgey M. 2004.Regulation of desmocollin gene expression in the epidermis: CCAAT/enhancer-binding proteins modulate early and late events in keratinocyte differentiation. Biochem J 380: 757–765.
142. Sonnenberg A, Liem RK. 2007. Plakins in development and disease. Exp Cell Res 313: 2189–2203.
143. Spindler V, Waschke J. 2011. Role of Rho GTPases in desmosomal adhesion and pemphigus pathogenesis. Ann Anat 193: 177–180.
144. Spindler V, Rotzer V, Dehner C, Kempf B, Gliem M, Radeva M, Hartlieb E, Harms GS, Schmidt E, Waschke J. 2013. Peptide-mediated desmoglein 3 cross-linking prevents pemphigus vulgaris autoantibody-induced skin blistering. J Clin Invest 123: 800–811.
145. Steinert PM, Marekov LN. 1999. Initiation of assembly of the cell envelope barrier structure of stratified squamous epithelia. Mol Biol Cell 10: 4247–4261.
146. Sumigray KD, Lechler T. 2011. Control of cortical microtubule organization and desmosome stability by centrosomal proteins. Bioarchitecture 1: 221–224.
147. Sumigray KD, Lechler T. 2012. Desmoplakin controls microvilli length but not cell adhesion or keratin organization in the intestinal epithelium. Mol Biol Cell 23: 792– 799.
148. Sumigray KD, Chen H, Lechler T. 2011. Lis1 is essential for cortical microtubule organization and desmosome stability in the epidermis. J Cell Biol 194: 631–642.
149. Swamynathan S, Kenchegowda D, Piatigorsky J. 2011. Regulation of corneal epithelial barrier function by Kruppellike transcription factor 4. Invest Ophthalmol Vis Sci 52: 1762–1769.
150. Szegedi A, Payer E, Czifra G, Toth BI, Schmidt E, Kovacs L, Blumberg PM, Biro T. 2009. Protein kinase C isoenzymes differentially regulate the differentiation-dependent expression of adhesion molecules in human epidermal keratinocytes. Exp Dermatol 18: 122–129.
151. Tachikawa T, Kohno Y, Matsui Y, Yoshiki S. 1986. In vitro early changes in intercellular junctions by treatment with a chemical carcinogen. Carcinogenesis 7: 885–892.
152. Tada H, Hatoko M, Tanaka A, Kuwahara M, Muramatsu T. 2000. Expression of desmoglein I and plakoglobin in skin carcinomas. J Cutan Pathol 27: 24–29.
153. The MT, Parkinson EK, Thurlow JK, Liu F, Fortune F, Wan H. 2011. A molecular study of desmosomes identifies a desmoglein isoform switch in head and neck squamous cell carcinoma. J Oral Pathol Med 40: 67–76.
154. Thomason HA, Scothern A, McHarg S, Garrod DR. 2010. Desmosomes: Adhesive strength and signalling in health and disease. Biochem J 429: 419–433.
155. Thomason HA, Cooper NH, Ansell DM, Chiu M, Merrit AJ, Hardman MJ, Garrod DR. 2012. Direct evidence that PKC-a positively regulates wound re-epithelialization: Correlation with changes in desmosomal adhesiveness. J Pathol 227: 346–356.
156. Todorovic V, Desai BV, Patterson MJ, Amargo EV, Dubash AD, Yin T, Jones JC, Green KJ. 2010. Plakoglobin regulates cell motility through Rho and fibronectin-dependent Src signaling. J Cell Sci 123: 3576–3586.
157. Tokonzaba E, Chen J, Cheng X, Den Z, Ganeshan R, Muller EJ, Koch PJ. 2013. Plakoglobin as a regulator of desmocollin gene expression. J Invest Dermatol 133: 2732–2740.
158. Tsang SM, Liu L, Teh MT, Wheeler A, Grose R, Hart IR, Garrod DR, Fortune F, Wan H. 2010. Desmoglein 3, via an interaction with E-cadherin, is associated with activation of Src. PLoS ONE 5: 14211.
159. Tsang SM, Brown L, Gadmor H, Gammon L, Fortune F, Wheeler A, Wan H. 2012a. Desmoglein 3 acting as an upstream regulator of Rho GTPases, Rac-1/Cdc42 inthe regulation of actin organisation and dynamics. Exp Cell Res 318: 2269–2283.
160. Tsang SM, Brown L, Lin K, Liu L, Piper K, O’Toole EA, Grose R, Hart IR, Garrod DR, Fortune F, et al. 2012b. Nonjunctional human desmoglein 3 acts as an upstream regulator of Src in E-cadherin adhesion, a pathway possibly involved in the pathogenesis of pemphigus vulgaris. J Pathol 227: 81–93.
161. Twiss F, de Rooij J. 2013. Cadherin mechanotransduction in tissue remodeling. Cell Mol Life Sci 70: 4101–4116.
162. Vandewalle C, Comijn J, De Craene B, Vermassen P, Bruyneel E, Andersen H, Tulchinsky E, Van Roy F, Berx G. 2005. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res 33: 6566–6578.
163. Wallis S, Lloyd S, Wise I, Ireland G, Fleming TP, Garrod D. 2000. The a isoform of protein kinase C is involved in signaling the response of desmosomes to wounding in cultured epithelial cells. Mol Biol Cell 11: 1077–1092.
164. Walsh R, Blumenberg M. 2011. Eph-2B, acting as an extracellular ligand, induces differentiation markers in epidermal keratinocytes. J Cell Physiol 227: 2330–2340.
165. Wan H, South AP, Hart IR. 2007. Increased keratinocyte proliferation initiated through downregulation of desmoplakin by RNA interference. Exp Cell Res 313: 2336–2344.
166. Wang Y, Amagai M, Minoshima S, Sakai K, Green KJ, Nishikawa T, Shimizu N. 1994. The human genes for desmogleins (DSG1 and DSG3) are located in a small region on chromosome 18q12. Genomics 20: 492–495.
167. Wanner R, Wolff B, Glowacki F, Kolde G, Wittig B. 1999. The loss of desmosomes after retinoic acid treatment results in an apparent inhibition of HaCaT keratinocyte differentiation. Arch Dermatol Res 291: 346–353.
168. Waschke J, Spindler V, Bruggeman P, Zillikens D, Schmidt G, Drenckhahn D. 2006. Inhibition of Rho A activity causes pemphigus skin blistering. J Cell Biol 175: 721–727.
169. White FH, Gohari K. 1984. A qualitative ultrastructural study of the intercellular spaces between epithelial cells treated in vivo with DMBA. J Oral Pathol 13: 231–243.
170. Whittock NV, Bower C. 2003. Genetic evidence for a novel human desmosomal cadherin, desmoglein 4. J Invest Dermatol 120: 523–530.
171. Wilanowski T, Caddy J, Ting SB, Hislop NR, Cerruti L, Auden A, Zhao LL, Asquith S, Ellis S, Sinclair R, et al. 2008. Perturbed desmosomal cadherin expression in grainy head-like 1-null mice. EMBO J 27: 886–897.
172. Wolf A, Rietscher K, Glass M, Huttelmaier S, Schutkowski M, Ihling C, Sinz A, Wingenfeld A, Mun A, Hatzfeld M. 2013. Insulin signaling via Akt2 switches plakophilin 1 function from stabilizing cell adhesion to promoting cell proliferation. J Cell Sci 126: 1832–1844.
173. Wong MP, Cheang M, Yorida E, Coldman A, Gilks CB, Huntsman D, Berean K. 2008. Loss of desmoglein 1 expression associated with worse prognosis in head and neck squamous cell carcinoma patients. Pathology 40: 611–616.
174. Yamazaki S, Uchiumi A, Katagata Y. 2012. Hsp40 regulates the amount of keratin proteins via ubiquitin-proteasome pathway in cultured human cells. Int J Mol Med 29: 165-168.
175. Yang L, Chen Y, Cui T, Knosel T, Zhang Q, Albring KF, Huber O, Petersen I. 2012. Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/b-catenin signaling pathway in human lung cancer. Carcinogenesis 33: 1863–1870.
176. Yin T, Getsios S, Caldelari R, Kowalczyk AP, Muller EJ, Jones JC, Green KJ. 2005. Plakoglobin suppresses keratinocyte motility through both cell–cell adhesion-dependent and-independent mechanisms. Proc Natl Acad Sci 102: 5420–5425.
177. Yong AA, Tey HL. 2012. Paraneoplastic pemphigus. Australas J Dermatol 54: 241–250.